Artificial intelligence for analysing chest CT images (MIB243)Product type:AdviceProgramme:Medtech innovation briefingPublished: 5 January 2021
Astegolimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6524]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Balloon dilation plus spiculiform electrosurgery towards the therapy of obstructive Airway Disease: Central Airway Fibrotic Stricture - benignStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Bronchoscopic intrabullous autologous blood instillation (BIABI) for the therapy of Emphysema: intractable with pneumothorax, COPD & Lung cancer, patients requiring lung biopsyStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Bronchoscopic thermal vapour ablation for upper-lobe emphysema (IPG652)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 12 June 2019
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing (NG114)Product type:GuidanceProgramme:NICE guidelinePublished: 5 December 2018
Chronic obstructive pulmonary disease in adults (QS10)Product type:Quality standardLast updated: 19 September 2023Published: 28 July 2011
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115)Product type:GuidanceProgramme:NICE guidelineLast updated: 26 July 2019Published: 5 December 2018
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment (HTE18)Product type:GuidanceProgramme:Health technology evaluationPublished: 30 April 2024
Digital technologies to support self-management of COPD: early value assessment (HTE19)Product type:GuidanceProgramme:Health technology evaluationLast updated: 4 February 2025Published: 19 December 2024
Dupilumab for treating moderate to severe chronic obstructive pulmonary disease ID6235Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease (IPG677)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 5 August 2020
Endobronchial nerve ablation for chronic obstructive pulmonary disease (IPG714)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 15 December 2021
Endobronchial valve insertion to reduce lung volume in emphysema (IPG600)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 20 December 2017
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant (IPG695)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 May 2021
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome (MIB281)Product type:AdviceProgramme:Medtech innovation briefingPublished: 7 December 2021
Human alpha1-proteinase inhibitor for treating emphysema (terminated appraisal) (TA965)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 March 2024
Insertion of endobronchial nitinol coils to improve lung function in emphysema (IPG517)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 March 2015
Itepekimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6547]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Lung volume reduction surgery for advanced emphysema (IPG114)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 February 2005
Mepolizumab for reducing eosinophilic exacerbations of chronic obstructive pulmonary disease [ID1237]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Mepolizumab for treating chronic obstructive pulmonary disease with eosinophil-associated exacerbations TSID12019Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
MT633 FreeO2 Automatic Oxygen TitrationStatus:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)Product type:AdviceProgramme:Medtech innovation briefingPublished: 1 October 2018
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202)Product type:GuidanceProgramme:NICE guidelinePublished: 20 August 2021
OxyMask for delivering oxygen therapy (MIB160)Product type:AdviceProgramme:Medtech innovation briefingPublished: 27 September 2018
RespiraSense (MT736)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
Roflumilast for treating chronic obstructive pulmonary disease (TA461)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 July 2017
Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancerStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
VIDAvision for lung volume analysis in emphysema (MIB148)Product type:AdviceProgramme:Medtech innovation briefingPublished: 5 June 2018